Nonpigmenting solitary fixed drug eruption after skin testing and intra-articular injection of triamcinolone acetonide

Citation
O. Sener et al., Nonpigmenting solitary fixed drug eruption after skin testing and intra-articular injection of triamcinolone acetonide, ANN ALLER A, 86(3), 2001, pp. 335-336
Citations number
9
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
ISSN journal
10811206 → ACNP
Volume
86
Issue
3
Year of publication
2001
Pages
335 - 336
Database
ISI
SICI code
1081-1206(200103)86:3<335:NSFDEA>2.0.ZU;2-W
Abstract
Background: Although several medications have been reported to cause fixed drug eruption (FDE) reactions, triamcinolone acetonide has not been previou sly described as an offending agent. Objective: To emphasize both an unprecedented causative agent and the extra ordinary development of a FDE, we describe this response in a 42-year-old f emale patient. Methods: Because her history included a questionable reaction to corticoste roid preparations, prick and intradermal testing with triamcinolone acetoni de was done to determine whether she could safely receive a triamcinolone a cetonide injection. Results: Both skin test procedures and the intra-articular administration o f triamcinolone acetonide caused FDEs on her right retroauricular area. Conclusions: Because any drug may induce a FDE by any administration route, physicians should be aware of this delayed skin reaction when skin testing drugs.